Jeffery Zimmer, DPM
Podiatrist · Medford, ORNPI 1588943708
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Steelhead Surgical Inc at 53.0% of the total. Reporting peaked in 2022 at $1,248 and has fallen 59.1% since, to $510 in 2025.
Across 51 payments — averaging $44.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$1K
- Treace Medical Concepts, Inc.$341
- Smith+Nephew$190
- Stryker$101
- Paratek Pharmaceuticals, Inc.$92
- DJO, LLC$55
- plus $283 from 10 others
What the payments were for
- Food & beverage$1,06247%
- Education$1,20053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 1 | $1,200 |
| Treace Medical Concepts, Inc. | 17 | $341 |
| Smith+Nephew | 5 | $190 |
| Stryker | 5 | $101 |
| Paratek Pharmaceuticals, Inc. | 4 | $92 |
| DJO, LLC | 3 | $55 |
| Tactile Systems Technology Inc | 2 | $45 |
| Merck | 3 | $37 |
| Orthofix Medical, Inc. | 2 | $37 |
| Amgen | 2 | $33 |
| KCI USA, Inc. | 2 | $29 |
| Wildwood Medical LLC | 1 | $24 |
| Medtronic | 1 | $23 |
| Acera Surgical, Inc. | 1 | $23 |
| GRT US Holding, Inc. | 1 | $17 |
| Biowound Solutions, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$112
How this compares
$2,262 in reported general payments places this provider in the 60th percentile of 74 podiatrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 42 | $524 |
| Oxycodone Hcl | 34 | $200 |
| Clindamycin Hcl | 19 | $118 |
| Mupirocin | 12 | $100 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $96 |
| Methylprednisolone | 16 | $94 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $93 |
| Cephalexin | 16 | $82 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Medford
- Rick McClureMedford$133K
- James HoldermannMedford$5K
- Heather HoldermannMedford$4K
- Michael DekorteMedford$2K
- Cyaandi DoveGrand Ronde$51K
- Stephen SchroederTigard$28K
- Colin MizuoHillsboro$18K
- Melinda NicholesPortland$15K
- Amanda KameryEugene$9K
- Peter PhamBeaverton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.